menu search

Jpmorgan chase ceo jamie dimon speaks: experts break down his comments on markets, fed, economy

Yahoo Finance spoke to experts including Nick Timiraos The Wall Street Journal chief economics correspo...

November 4, 2023, 11:00 am

Bectran to sponsor credit research foundation’s november forum as a platinum partner

CHICAGO, Nov. 03, 2023 (GLOBE NEWSWIRE) — Bectran, Inc., the industry leader in innovative, cutting-edge technology for credit, collections and acco...

November 3, 2023, 9:31 pm

Why is altamira therapeutics (cyto) stock up 28% today?

Altamira Therapeutics (NASDAQ: CYTO ) stock is rising higher on Friday despite a lack of news from the...

November 3, 2023, 7:53 am

Axis capital holdings limited (axs) q3 2023 earnings call transcript

AXIS Capital Holdings Limited (NYSE:AXS ) Q3 2023 Earnings Conference Call November 2, 2023 9:30 AM ET Company Participants ...

November 2, 2023, 3:43 pm

Kura oncology and mirati therapeutics enter into clinical collaboration and supply agreement to evaluate ko-2806 and adagrasib in krasᴳ¹²ᶜ-mutated nsclc

– Ongoing Phase 1 dose-escalation trial of KO-2806 (FIT-001) expected to begin dosing patients in combination with adagrasib by mid-2024 – SAN DIE...

November 2, 2023, 11:30 am

Scotts miracle-gro (smg) q4 earnings & sales beat estimates

The decline in sales of Scotts miracle-Gro (SMG) is due to lower sales in the U.S. Consumer and Hawthor...

November 2, 2023, 9:01 am

Why scotts miracle-gro stock soared today

Scotts miracle-Gro's revenue is falling and profits have evaporated. Management says it made hard choic...

November 1, 2023, 3:54 pm

Scotts miracle-gro's stock posts biggest one-day gain in 15 years after narrower-than-expected loss

Scotts miracle-Gro Co.'s stock soared 21% Wednesday, chalking up its biggest one-day gain since Aug. 1,...

November 1, 2023, 2:25 pm

Masonic cancer center, university of minnesota to present data in poster presentation human data readout for phase 1 study to evaluate hcw9218 in solid tumors at sitc 38th annual meeting

HCW9218 is the lead product candidate of HCW Biologics Inc. miraMAR, Fla., Nov. 01, 2023 (GLOBE NEWSWIR...

November 1, 2023, 11:30 am

Cdw corporation (cdw) q3 2023 earnings call transcript

CDW Corporation (NASDAQ:CDW ) Q3 2023 Earnings Conference Call November 1, 2023 8:30 AM ET Company Participants Steve O'Brien - Investor Relations Chr...

November 1, 2023, 9:58 am

Admirals uk's loss deepens in 2022 despite estonian parent turned record figure

Admiral Markets UK Limited, the FCA-regulated subsidiary of Eatonia-based Ad...

November 1, 2023, 7:14 am

Uae's crypto landscape thrives as 59% embrace long-term view: kucoin survey

The cryptocurrency exchange KuCoin has released the findings of a new survey offering insights into the crypto landscape in the United Arab E...

October 31, 2023, 1:27 pm

Is abbvie still a good dividend stock to buy?

AbbVie's best-selling product lost patent-protected market exclusivity in the U.S. this year. Competition with lower-cost biosimilar versions of Hu...

October 31, 2023, 5:23 am

Avangrid, inc. (agr) q3 2023 earnings call transcript

Avangrid, Inc. (NYSE:AGR ) Q3 2023 Earnings Conference Call October 26, 2023 10:00 AM ET Company Participants Alvaro Ortega - VP of Finance, IR & Trea...

October 28, 2023, 3:54 pm

Stockholder alert: the m&a class action firm continues investigating the merger – mrtx, faze, hes, tgh

NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) — Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the �...

October 27, 2023, 10:00 pm

Lumiradx announces receipt of nasdaq delisting determination; plans to appeal

LONDON, Oct. 27, 2023 (GLOBE NEWSWIRE) — On October 24, 2023, LumiraDx Limited (Nasdaq: LMDX)(the “...

October 27, 2023, 8:45 pm

Abbvie surprises in 3q with better than expected humira sales

Abbvie (NYSE:ABBV) raised its 2023 profit guidance after a strong quarterly earnings report driven by demand for newer drugs and better-than-expected ...

October 27, 2023, 10:31 am

Abbvie's humira sales sink 36% but guidance lifted on growth from other drugs

AbbVie raises earnings guidance for fiscal 2023....

October 27, 2023, 8:28 am

Abbvie raises profit forecast after humira, newer drugs drive results beat

AbbVie on Friday raised its annual profit forecast after beating quarterly earnings estimates, helped by a lower-than-feared drop in sales of its bloc...

October 27, 2023, 7:42 am

Abbvie results beat expectations despite low-cost competition to blockbuster humira

AbbVie Inc. ABBV, -0.04% on Friday reported third-quarter sales and profit that topped analyst expectations and raised its full-year earnings outlook,...

October 27, 2023, 7:42 am


Search within

Pages Search Results: